Pauline Jen Ryan
Corporate Officer/Principal bei OCULAR THERAPEUTIX, INC.
Aktive Positionen von Pauline Jen Ryan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC. | Corporate Officer/Principal | - | - |
| Red Sky Partners LLC | Corporate Officer/Principal | 01.07.2014 | - |
Karriereverlauf von Pauline Jen Ryan
Ehemalige bekannte Positionen von Pauline Jen Ryan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Verik Bio, Inc. | Vorstandsvorsitzender | 01.04.2012 | 01.11.2017 |
| PROTEOSTASIS THERAPEUTICS, INC. | Corporate Officer/Principal | 01.10.2007 | 01.08.2011 |
| IMMUNOGEN, INC. | Corporate Officer/Principal | 01.05.1999 | 26.07.2007 |
Ausbildung von Pauline Jen Ryan
| Northwestern University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OCULAR THERAPEUTIX, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
| Red Sky Partners LLC | |
| Verik Bio, Inc. | |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Pauline Jen Ryan
- Erfahrung
